HBeAg seroconversion at the end of 1 year was 29% for combination, 18% for lamivudine, 19% for interferon and 4% in plac治疗一年后，HBEAG血清转换情况为：联合治疗为29%，拉米夫啶为18%，干扰素为19%，安慰组为4%。
Results After days cell culturing in concentration of ×0 Ampoule/ml of attenuated HAV, HBeAg content in cult果 ×0 - Ampoule/ ml的减毒HAV作用Hep G . .细胞 d后,培养上清液的HBe Ag浓度为( 7. ± .8) S/ CO,低于对照组的( 0 .± .77) S/ CO,组比较差异有非常显著性( P<0 .0
Results:Serum HBV-DNA positive rates of the patients with HBsAg,HBeAg and HBc Ab triplex positive was 00% (9/9),the DNA 果 :经荧光定量PCR检测 9例HBsAg、HBeAg、HBcAb均阳性的标本 ,其血清HBV -DNA全部阳性 ,DNA测值范围 .8× 0 ～ .8× 0 8copy/ml;
Objective To evaluate the relationship between HBV PreS1 antigen and the virus replication index(HBeAg and HBV-DNA) and 目的研究HBV前S1抗原检测的临床价值,即HBVPreS1抗原与具有病毒活动性复制意义的指标HBeAg和HBV-DNA之间的相关性其与肝功能指标ALT之间的关系。
Results The rate of HbeAg and HBV DNA negative transformation was higher in group Ⅲ than in group Ⅰ and group Ⅱ. Decreas结果Ⅲ组治疗后乙型肝炎病毒e抗原 (HBeAg)和乙肝病毒脱氧核糖核酸 (HBV DNA)阴转率高于Ⅰ组或Ⅱ组 ,Ⅲ组降低丙氨酸氨基转移酶 (ALT)和天冬氨酸氨基转移酶 (AST)的作用强于Ⅱ组 ,Ⅰ组降低ALT和AST的作用也强于Ⅱ组。